Introducing scar management and Dermatix® products

Caused by accident, surgery and even diseases, scars are a natural part of the healing process. Scars occur as the wound heals and the skin is repaired and are influenced by 5 factors:

  • Age
  • Genetics (skin types)
  • Location on the body
  • Previous history
  • Wound infection

Regardless of where the scar is or even how old it is they can sometimes have distressing side effects such as: depression, social anxiety, avoidance, and generally low self-esteem.

The good news is that you do not have to wait for time to improve your scars. Dermatix® – available in a range of silicone based products is clinically proven to significantly improve the appearance of scars. Suitable for existing prominent immature and new scars, Dermatix® even reduces scarring following surgery, burns and other injuries. Dermatix® is available in two forms: as a Silicone Gel and as Silicone Sheets (both clear and fabric backed). Silicone is the most frequently used non-invasive treatment in scar management.

Dermatix® is now available on the NHS as well as through online ordering and from your local pharmacist. It is supplied in a 15g tube and can be obtained with or without a prescription. A 60g tube is available for those who have larger scars. Dermatix® is also supplied as a sheet (clear or fabric) in four different sizes.

Problems with scars

Scars may take many months to flatten and fade after injury, but problematic scars may have the following effects:

  • Grow bigger
  • Remain red/dark and raised without fading
  • Cause discomfort, itching or pain
  • Restrict the movement of a joint
  • Cause distress because of appearance

Dermatix® is used and recommended by plastic surgeons, dermatologists and leading specialists worldwide, to effectively treat and reduce scarring. It is clinically proven to soften, flatten and smooth scars, relieving the itching, pain and discomfort associated with them. [1] Dermatix® is easily applied to all areas of the body, including the face, joints and other parts of the skin.

References:

  1. References:Mustoe TA et al. Plast Reconstr Surg 2002;110:560-571
  • Print this page
  • Bookmark with
Email signup
For special offers and promotions

Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.gov.uk. Adverse events should also be reported to Meda Pharmaceuticals Ltd. UK.

Registered Office: Meda Pharmaceuticals Ltd, Scotland, 249 West Street, Glasgow, G2 4RB, (Scotland) 043236
Tel: 0800 783 4995, Email: dermatix@medapharma.co.uk

38.107.179.211
Product added to favourites

Please choose an option below to continue.

favourites continue shopping

Product successfully added to basket

Please choose an option below to continue.

checkout continue shopping